Information on IRF4-DN
Basic details
Name: Combined immunodeficiency with skin-hair depigmentation | Acronym: IRF4-DN
Alt. names: Early-onset PAD with T cell anomalies and skin-hair depigmentation | Hypogammaglobulinemia, T cell abnormalities and skin-hair depigmentation
Gene: IRF4 | MOI: Autosomal dominant | Mechanism of action: Negative Dominance
No. of cases in DB: 4 | First reported in: 2023
Last updated on: 2024-10-25 16:39:55 by Xiao P. Peng
OMIM:
Orphanet: -
MONDO: -
DOID: -
ClinGen:
Description
Thouenon et al. (2023) described a heterozygous neomorphic IAD domain variant (c.1075 T>C, p.(F359L)) in 3 patients from a 2-generation family who presented with hypogammaglobulinemia and early onset recurrent bacterial, viral and fungal infections, predominantly sinorespiratory, GI and mucocutaneous, as well as skin and hair depigmentation (PMID: 36917008). One patient developed TNF inhibitor-responsive inflammatory bowel disease and liver disease with evidence of prominent CD8+ T cell infiltration on pathology. Despite normal overall B cell counts and normal proportions of switched memory B cells in adulthood, all patients had lower proportions of immature T and B cell populations in the blood – namely, reduced naïve vs memory T cells and reduced plasmablast/plasma cell counts. Two patients also showed absolute T cell lymphopenia. Defective IRF4 mutant protein showed altered binding at ISRE, which leads to defective plasma cell differentiation.
Management
Description of management option has not been reviewed yet.
Please mind that full curation of this condition has not been completed yet. It is currently ongoing.
4 reported cases added to GenIA
AD: Age at genetic diagnosis; AFM: age at first manifestation; PMID: PubMed ID; GRID: GenIA reference ID (ref. not in PubMed).
Summary of clinical findings
[Considering only Definitive and Possible cases]
Please mind that full curation of this condition has not been completed yet. It is currently ongoing.
Summary of treatment outcomes
[Considering only Definitive and Possible cases]
Treatment ⓘ | Responses & clinical indications |
---|
Please mind that full curation of this condition has not been completed yet. It is currently ongoing.